Asset Allocation

As of November 30, 2025.
Type % Net
Cash 0.10%
Stock 49.23%
Bond 36.00%
Convertible 0.51%
Preferred 6.85%
Other 7.31%
View Asset Allocation
Start Trial

Market Capitalization

As of November 30, 2025
Large 52.06%
Mid 14.62%
Small 33.32%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 87.84%    % Emerging Markets: 3.01%    % Unidentified Markets: 9.14%

Americas 86.44%
80.46%
Canada 7.90%
United States 72.56%
5.98%
Brazil 2.99%
As of November 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 4.40%
United Kingdom 1.95%
2.46%
France 0.53%
Germany 0.00%
Ireland 0.01%
Italy 0.00%
Netherlands 0.00%
Switzerland 0.24%
0.00%
0.00%
Greater Asia 0.01%
Japan 0.00%
0.00%
0.01%
South Korea 0.00%
Taiwan 0.01%
0.00%
Unidentified Region 9.14%

Bond Credit Quality Exposure

AAA 0.00%
AA 49.18%
A 0.72%
BBB 1.11%
BB 13.06%
B 7.36%
Below B 0.86%
    CCC 0.71%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.15%
Not Rated 0.00%
Not Available 27.71%
Short Term 0.00%
As of November 30, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
20.32%
Materials
1.66%
Consumer Discretionary
11.64%
Financials
5.96%
Real Estate
1.06%
Sensitive
54.64%
Communication Services
6.52%
Energy
18.52%
Industrials
8.36%
Information Technology
21.24%
Defensive
21.74%
Consumer Staples
1.95%
Health Care
9.85%
Utilities
9.94%
Not Classified
3.30%
Non Classified Equity
0.25%
Not Classified - Non Equity
3.05%
As of November 30, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of November 30, 2025
Type % Net
Government 57.55%
Corporate 18.13%
Securitized 1.27%
Municipal 0.00%
Other 23.05%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.86%
Less than 1 Year
0.86%
Intermediate
48.10%
1 to 3 Years
14.79%
3 to 5 Years
22.65%
5 to 10 Years
10.66%
Long Term
50.37%
10 to 20 Years
1.19%
20 to 30 Years
49.19%
Over 30 Years
0.00%
Other
0.67%
As of November 30, 2025
View Bond Maturity Exposure
Start Trial